Caricamento...
BAY 81-8973, a full-length recombinant factor VIII for the treatment of hemophilia A: product review
BAY 81-8973 (Kovaltry(®)) is an unmodified, full-length recombinant factor VIII (rFVIII) approved for the prevention and treatment of bleeding episodes in patients with hemophilia A. The amino acid sequence for BAY 81-8973 is identical to that of sucrose-formulated rFVIII (rFVIII-FS; Kogenate(®) FS/...
Salvato in:
| Pubblicato in: | Ther Adv Hematol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6041863/ https://ncbi.nlm.nih.gov/pubmed/30013766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620718777903 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|